You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Ethical Issues in International Biomedical Research is the definitive book on the ethics of research involving human subjects in developing countries. Using 21 actual case studies, it covers the most controversial topics, including the ethics of placebo research in Africa, what benefits should be provided to the community after completion of a research trial, how to address conflicts between IRBs in developed and developing countries, and undue inducement of poor people in developing countries. Each case is accompanied by two expert commentaries, written by many of the worlds leading experts in bioethics as well as new voices with research experience in developing countries. No other volume has this scope. Students in bioethics, public and international health, and ethics will find this book particularly useful.
The Oxford Textbook of Clinical Research Ethics is the first comprehensive and systematic reference on clinical research ethics. Under the editorship of experts from the U.S. National Institutes of Health of the United States, the book's 73 chapters offer a wide-ranging and systematic examination of all aspects of research with human beings. Considering the historical triumphs of research as well as its tragedies, the textbook provides a framework for analyzing the ethical aspects of research studies with human beings. Through both conceptual analysis and systematic reviews of empirical data, the contributors examine issues ranging from scientific validity, fair subject selection, risk benefit ratio, independent review, and informed consent to focused consideration of international research ethics, conflicts of interests, and other aspects of responsible conduct of research. The editors of The Oxford Textbook of Clinical Research Ethics offer a work that critically assesses and advances scholarship in the field of human subjects research. Comprehensive in scope and depth, this book will be a crucial resource for researchers in the medical sciences, as well as teachers and students.
In this revised fourth edition of the classic textbook, Devettere updates most chapters, adding new cases on the following: overriding advance directives, the palliative care movement, prenatal life and abortion, neonatal testing and mandatory vaccinations, facial transplantations, genetic testing, and legal issues surrounding the Affordable Care Act.
Sharing biological resources-critical for new medicines and vaccines-has declined as countries and scientists dispute rights over research.
"Since the publication of the first edition of Beyond Consent, issues of justice remain critical in discussions, debates, and policy making in biomedical research in involving human subjects. The second edition adds new content in two different ways, first by asking authors to examine the issues identified in the first edition by asking what has changed and what new issues arise in the contemporary environment, and second by adding chapters to take on issues that are salient today and looking forward. The result is a new treatment of the issues of justice in research through fresh perspectives and by examining the latest issues. The editors have assembled a group of leading scholars and researchers as contributors, and author the final chapter themselves. This collection is a vital resource for students and scholars of bioethics, medicine, and public health policy; as well as for members of institutional review boards (IRBs), research administrators, and policy makers."--
Patients at Risk opens a window onto the hidden world of clinical research trials. It advises those who are considering participation in such a trial, how these trials actually work, and how they are fundamentally exploitative of the patients' rights. Accessible, eye-opening, and practical in its recommendations for both patients and for reform, Patients at Risk s sure to be controversial.
Structure, Agency and Biotechnology argues for the significance of sociological theory and highlights the insights it can offer to the study of agricultural biotechnology. Cautioning against a simplistic reading of the GM controversy as merely a debate of science versus politics, Aristeidis Panagiotou suggests that the discussion should be embedded in the wider social, political, economic and cultural contexts. Structure, Agency and Biotechnology assesses the 2012 Rothamsted GM wheat trials and proposes that the tension underlying GM technology should be resolved through sustained dialogue, public involvement and broad scientific consensus.